481 related articles for article (PubMed ID: 10676659)
1. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini R; Koivunen E; Kain R; Lahdenranta J; Sakamoto M; Stryhn A; Ashmun RA; Shapiro LH; Arap W; Ruoslahti E
Cancer Res; 2000 Feb; 60(3):722-7. PubMed ID: 10676659
[TBL] [Abstract][Full Text] [Related]
2. Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth.
Yokoyama Y; Ramakrishnan S
Cancer; 2005 Jul; 104(2):321-31. PubMed ID: 15952188
[TBL] [Abstract][Full Text] [Related]
3. A unified mechanism for aminopeptidase N-based tumor cell motility and tumor-homing therapy.
Liu C; Yang Y; Chen L; Lin YL; Li F
J Biol Chem; 2014 Dec; 289(50):34520-9. PubMed ID: 25359769
[TBL] [Abstract][Full Text] [Related]
4. Modification of cyclic NGR tumor neovasculature-homing motif sequence to human plasminogen kringle 5 improves inhibition of tumor growth.
Jiang W; Jin G; Ma D; Wang F; Fu T; Chen X; Chen X; Jia K; Marikar FM; Hua Z
PLoS One; 2012; 7(5):e37132. PubMed ID: 22590653
[TBL] [Abstract][Full Text] [Related]
5.
Kis A; Dénes N; Szabó JP; Arató V; Beke L; Matolay O; Enyedi KN; Méhes G; Mező G; Bai P; Kertész I; Trencsényi G
Biomed Res Int; 2021; 2021():6642973. PubMed ID: 33778075
[TBL] [Abstract][Full Text] [Related]
6. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin.
Shim JS; Kim JH; Cho HY; Yum YN; Kim SH; Park HJ; Shim BS; Choi SH; Kwon HJ
Chem Biol; 2003 Aug; 10(8):695-704. PubMed ID: 12954328
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an Integrin α
Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
[TBL] [Abstract][Full Text] [Related]
8. Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma.
Otsuki T; Nakashima T; Hamada H; Takayama Y; Akita S; Masuda T; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Miyata Y; Miyake M; Kohno N; Okada M; Hattori N
Eur Respir J; 2018 May; 51(5):. PubMed ID: 29519924
[TBL] [Abstract][Full Text] [Related]
9. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.
Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F
Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818
[TBL] [Abstract][Full Text] [Related]
10. Activity screening and structure-activity relationship of the hit compounds targeting APN/CD13.
Wang X; Jing F; Zhu H; Fang H; Zhang J; Xu W
Fundam Clin Pharmacol; 2011 Apr; 25(2):217-28. PubMed ID: 20636366
[TBL] [Abstract][Full Text] [Related]
11. A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis.
Zheng YB; Gong JH; Liu XJ; Li Y; Zhen YS
Mol Carcinog; 2017 May; 56(5):1395-1404. PubMed ID: 27991698
[TBL] [Abstract][Full Text] [Related]
12. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.
Bauvois B; Dauzonne D
Med Res Rev; 2006 Jan; 26(1):88-130. PubMed ID: 16216010
[TBL] [Abstract][Full Text] [Related]
13. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells.
Curnis F; Arrigoni G; Sacchi A; Fischetti L; Arap W; Pasqualini R; Corti A
Cancer Res; 2002 Feb; 62(3):867-74. PubMed ID: 11830545
[TBL] [Abstract][Full Text] [Related]
14. Design of Aminopeptidase N Inhibitors as Anti-cancer Agents.
Amin SA; Adhikari N; Jha T
J Med Chem; 2018 Aug; 61(15):6468-6490. PubMed ID: 29630364
[TBL] [Abstract][Full Text] [Related]
15. An NGR-integrated and enediyne-energized apoprotein shows CD13-targeting antitumor activity.
Zheng YB; Shang BY; Li Y; Zhen YS
Biomed Pharmacother; 2013 Mar; 67(2):164-71. PubMed ID: 23206754
[TBL] [Abstract][Full Text] [Related]
16. In vivo assessment of aminopeptidase N (APN/CD13) specificity of different
Kis A; Dénes N; Szabó JP; Arató V; Jószai I; Enyedi KN; Lakatos S; Garai I; Mező G; Kertész I; Trencsényi G
Int J Pharm; 2020 Nov; 589():119881. PubMed ID: 32946975
[TBL] [Abstract][Full Text] [Related]
17. MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model.
Akita S; Hattori N; Masuda T; Horimasu Y; Nakashima T; Iwamoto H; Fujitaka K; Miyake M; Kohno N
Cancer Sci; 2015 Jul; 106(7):921-8. PubMed ID: 25950387
[TBL] [Abstract][Full Text] [Related]
18. NGR Tumor-Homing Peptides: Structural Requirements for Effective APN (CD13) Targeting.
Graziadio A; Zanda M; Frau S; Fleming IN; Musolino M; Dall'Angelo S; Baldassarre M; Piras M
Bioconjug Chem; 2016 May; 27(5):1332-40. PubMed ID: 27077642
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and activity evaluation of a new 5-fluorouracil prodrug containing an Asn-Gly-Arg(NO2)COOCH3 tripeptide.
Luan Y; Jing F; Zhang J; Zou M; Wang X; Jia Y; Liu N; Mou J; Xu W
Protein Pept Lett; 2012 Oct; 19(10):1122-31. PubMed ID: 22512656
[TBL] [Abstract][Full Text] [Related]
20. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation.
Bhagwat SV; Lahdenranta J; Giordano R; Arap W; Pasqualini R; Shapiro LH
Blood; 2001 Feb; 97(3):652-9. PubMed ID: 11157481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
